vidarabine has been researched along with Ascites in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Dong, J; Meng, G; Wei, J; Wu, J; Zhang, H; Zhang, Y; Zuo, S | 1 |
| Kelleher, DK; Thews, O; Vaupel, P | 1 |
2 other study(ies) available for vidarabine and Ascites
| Article | Year |
|---|---|
Recombinant adenovirus expressing the fusion protein PD1PVR improves CD8
Topics: Adenoviridae; Animals; Antineoplastic Agents; Ascites; Carcinoma, Hepatocellular; CD8-Positive T-Lymphocytes; Cell Line, Tumor; Disease Models, Animal; Immunologic Surveillance; Immunosuppression Therapy; Inflammation; Liver Neoplasms; Lymphocyte Activation; Lymphocytes, Tumor-Infiltrating; Male; Mice, Inbred C57BL; Oncolytic Viruses; Recombinant Fusion Proteins; Treatment Outcome; Vidarabine; Virus Replication | 2021 |
In vivo oxygen consumption rate of DS sarcoma cells on inhibition of DNA synthesis.
Topics: Animals; Antineoplastic Agents; Ascites; Cell Division; Depression, Chemical; DNA, Neoplasm; Lovastatin; Male; Oxygen Consumption; Rats; Rats, Sprague-Dawley; Sarcoma, Experimental; Vidarabine | 1996 |